Blog
RSS FeedPosted by Michael Wonder on 04 Dec 2022
Anti-viral drug should not be first choice in treating COVID-19
3 December 2022 - The most widely prescribed anti-viral drug in Australia, molnupiravir, should no longer be routinely given for ...
Posted by Michael Wonder on 03 Dec 2022
Hopes $55k breast cancer drug Keytruda will get PBS listing
3 December 2022 - Women with triple negative breast cancer have been given new hope that immunotherapy drug Keytruda will ...
Posted by Michael Wonder on 02 Dec 2022
Agenda for the December 2022 PBAC intracycle meeting
2 December 2022 - The agenda for the December 2022 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 30 Nov 2022
Schedule of Pharmaceutical Benefits - 1 December 2022
1 December 2022 - The December 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 29 Nov 2022
External consultation on the draft revised post-market review framework (deadline extension)
29 November 2022 - The Department of Health and Aged Care has received a request to extend the consultation period on ...
Posted by Michael Wonder on 28 Nov 2022
Type 2 diabetes drug shortage: Victoria’s Ozempic, Trulicity supplies limited until March
28 November 2022 - Type 2 diabetes sufferers are spending hours driving around the suburbs begging pharmacists for a drug that’s ...
Posted by Michael Wonder on 27 Nov 2022
Cheaper medicines for high cholesterol and chronic heart failure
28 November 2022 - From 1 December 2022, Australians with high cholesterol, chronic heart failure, and a potentially life-threatening blood cell ...
Posted by Michael Wonder on 27 Nov 2022
Cost of life-saving heart disease drugs slashed, saving patients thousands
27 November 2022 - Life-saving medicines that tackle Australia's biggest killer are about to be added to the Pharmaceutical Benefits ...
Posted by Michael Wonder on 24 Nov 2022
Outcome in relation to discussion of COVID-19 oral treatments – November 2022 PBAC meeting
24 November 2022 - A PBAC outcome in relation to discussion of COVID-19 oral treatments at the November 2022 meeting has ...
Posted by Michael Wonder on 23 Nov 2022
Agenda for the March 2023 PBAC meeting
23 November 2022 - The agenda for the March 2023 PBAC meeting is now available. ...
Posted by Michael Wonder on 18 Nov 2022
Medicines industry calls for discount rate reduction now
18 November 2022 - Medicines Australia welcomes the recommendation to lower the discount rate for medicines and vaccines but questions ...
Posted by Michael Wonder on 18 Nov 2022
PBAC Public Summary Document (November 2022)
18 November 2022 - The Public Summary Documents for the Review of the base-case discount rate in the PBAC Guidelines from ...
Posted by Michael Wonder on 17 Nov 2022
New COVID-19 vaccines for eligible Australians
15 November 2022 - The Australian Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) on ...
Posted by Michael Wonder on 12 Nov 2022
NSW pharmacists to prescribe the pill, antibiotics in health shake-up
13 November 2022 - Pharmacists will be able to prescribe a range of meds and repeat scripts under a NSW government ...
Posted by Michael Wonder on 11 Nov 2022
Public Summary Documents (first time decisions not to recommend and deferrals) - July 2022 PBAC meeting
11 November 2022 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2022 PBAC ...